Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01344005
Other study ID # CDR0000699222
Secondary ID WCTU-EL-CIDEU-21
Status Not yet recruiting
Phase N/A
First received April 27, 2011
Last updated August 23, 2013
Start date June 2011

Study information

Verified date April 2011
Source National Cancer Institute (NCI)
Contact n/a
Is FDA regulated No
Health authority Unspecified
Study type Interventional

Clinical Trial Summary

RATIONALE: Diagnostic procedures, such as an urgent chest x-ray, may help in planning cancer treatment. It is not yet known whether standard medical care is more effective than an urgent x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.

PURPOSE: This randomized clinical trial is studying standard medical care to see how well it works compared with an urgent chest x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.


Description:

OBJECTIVES:

Primary

- To determine the prevalence of extra-NICE symptoms in patients consulting in UK general practice.

- To determine the proportion of patients who agree to participate in the trial.

- To determine the proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers.

Secondary

- To determine the best way to train general practitioners to identify and recruit eligible patients into the trial.

- To determine the most effective method of presenting the trial (and randomization) to patients.

- To determine the barriers to recruitment and how to overcome those barriers.

- To determine the best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays.

- To determine the best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'.

- To determine the stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer.

OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms.

- Arm A: Patients are managed as per the National Institute for Health and Clinical Excellence (NICE) guidelines.

- Arm B: Patients are referred for an urgent chest x-ray according to extra-NICE guidelines.

General practitioners from South East Wales are surveyed to assess their level of interest in the proposed full trial. For the feasibility study, 20 South East Wales general practices and 6 South Yorkshire general practices are selected. General practitioners are trained to recruit all patients who fulfill the extra-NICE criteria as well as those who do not.

Patients complete questionnaires (HADS, EQ-5D, and ICECAP[O]) at baseline and at 2 months to measure quality of life and health economic analysis of the cost-effectiveness of extra-NICE guidelines.

Peer Reviewed and Funded or Endorsed by Cancer Research UK.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 386
Est. completion date
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group 60 Years and older
Eligibility DISEASE CHARACTERISTICS:

- Patients over 60 seeing a participating General Practitioner

- Currently smokes 10 or more pack years, meeting at least one of the following criteria:

- New or altered cough of any duration reported to primary care

- Increased breathlessness or wheezing (with or without purulent sputum)

- Do not qualify for an urgent referral for a chest x-ray under the National Institute for Health and Clinical Excellence (NICE) guidelines (i.e., hemoptysis or unexplained or persistent [lasting > 3 weeks] signs or symptoms), including having any of the following:

- Cough

- Chest/shoulder pain

- Dyspnea

- Weight loss

- Chest signs

- Hoarseness

- Finger clubbing

- Features suggestive of metastasis from a lung cancer (e.g., in the brain, bone, liver, or skin)

- Cervical/supraclavicular lymphadenopathy

PATIENT CHARACTERISTICS:

- Not specified

PRIOR CONCURRENT THERAPY:

- No chest x-ray within in past 3 months

- No need for a chest x-ray within the next 3 weeks for reasons other than those listed under Disease Characteristics

Study Design

Allocation: Randomized, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
caregiver-related intervention or procedure

questionnaire administration

Procedure:
quality-of-life assessment

radiography


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Wales Cancer Trials Unit

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of extra-NICE symptoms in patients consulting in UK general practice No
Primary Proportion of patients who agree to participate in the trial No
Primary Proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers No
Secondary Best way to train general practitioners to identify and recruit eligible patients into the trial No
Secondary Most effective method of presenting the trial (and randomization) to patients No
Secondary Barriers to recruitment and how to overcome those barriers No
Secondary Best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays No
Secondary Best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE' No
Secondary Stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer No
Secondary False-positive and false-negative rates for chest x-rays No
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk